ARIAD PHARMACEUTICALS INC Operating Cash Flow
ARIAD PHARMACEUTICALS INC reported Operating Cash Flow of -$52.41 million for the 3-month period ending 2014-03-31, per its 10-Q filed 2014-05-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2014-05-09
- ARIAD PHARMACEUTICALS INC net cash provided by (used in) operating activities for the quarter ending 2014-03-31 was -$52.41M.
- ARIAD PHARMACEUTICALS INC net cash provided by (used in) operating activities for the quarter ending 2013-12-31 was -$51.57M.
- ARIAD PHARMACEUTICALS INC net cash provided by (used in) operating activities for the quarter ending 2013-09-30 was -$56.17M.
- ARIAD PHARMACEUTICALS INC net cash provided by (used in) operating activities for the quarter ending 2013-06-30 was -$45.69M.
- ARIAD PHARMACEUTICALS INC net cash provided by (used in) operating activities for fiscal 2013 was -$221.88M.
- ARIAD PHARMACEUTICALS INC net cash provided by (used in) operating activities for fiscal 2012 was -$153.68M.
- ARIAD PHARMACEUTICALS INC net cash provided by (used in) operating activities for fiscal 2011 was -$53.26M, a 929.88% decline from fiscal 2010.
- ARIAD PHARMACEUTICALS INC net cash provided by (used in) operating activities for fiscal 2010 was $6.42M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2014-03-31 | -$52.41M 10-Q · filed 2014-05-09 | -$103.98M derived: sum of 2 quarters · filed 2014-05-09 | -$160.15M derived: sum of 3 quarters · filed 2014-05-09 | -$205.84M derived: sum of 4 quarters · filed 2014-05-09 |
| 2013-12-31 | -$51.57M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | -$107.74M derived: sum of 2 quarters · filed 2014-03-03 | -$153.43M derived: sum of 3 quarters · filed 2014-03-03 | -$221.88M 10-K · filed 2014-03-03 |
| 2013-09-30 | -$56.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$101.86M derived: sum of 2 quarters · filed 2013-11-12 | -$170.31M 10-Q · filed 2013-11-12 | -$211.40M derived: sum of 4 quarters · filed 2014-05-09 |
| 2013-06-30 | -$45.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | -$114.14M 10-Q · filed 2013-08-09 | -$155.24M derived: sum of 3 quarters · filed 2014-05-09 | -$199.67M derived: sum of 4 quarters · filed 2014-05-09 |
| 2013-03-31 | -$68.45M 10-Q · filed 2014-05-09 | -$109.54M derived: sum of 2 quarters · filed 2014-05-09 | -$153.97M derived: sum of 3 quarters · filed 2014-05-09 | -$191.57M derived: sum of 4 quarters · filed 2014-05-09 |
| 2012-12-31 | -$41.09M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | -$85.52M derived: sum of 2 quarters · filed 2014-03-03 | -$123.12M derived: sum of 3 quarters · filed 2014-03-03 | -$153.68M 10-K · filed 2014-03-03 |
| 2012-09-30 | -$44.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$82.03M derived: sum of 2 quarters · filed 2013-11-12 | -$112.59M 10-Q · filed 2013-11-12 | -$135.25M derived: sum of 4 quarters · filed 2014-03-03 |
| 2012-06-30 | -$37.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | -$68.16M 10-Q · filed 2013-08-09 | -$90.82M derived: sum of 3 quarters · filed 2014-03-03 | -$85.98M derived: sum of 4 quarters · filed 2014-03-03 |
| 2012-03-31 | -$30.56M 10-Q · filed 2013-05-10 | -$53.23M derived: sum of 2 quarters · filed 2014-03-03 | -$48.38M derived: sum of 3 quarters · filed 2014-03-03 | -$66.55M derived: sum of 4 quarters · filed 2014-03-03 |
| 2011-12-31 | -$22.66M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | -$17.82M derived: sum of 2 quarters · filed 2014-03-03 | -$35.99M derived: sum of 3 quarters · filed 2014-03-03 | -$53.26M 10-K · filed 2014-03-03 |
| 2011-09-30 | $4.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | -$13.33M derived: sum of 2 quarters · filed 2012-11-09 | -$30.60M 10-Q · filed 2012-11-09 | -$42.96M derived: sum of 4 quarters · filed 2013-03-01 |
| 2011-06-30 | -$18.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | -$35.44M 10-Q · filed 2012-08-09 | -$47.80M derived: sum of 3 quarters · filed 2013-03-01 | -$49.26M derived: sum of 4 quarters · filed 2013-03-01 |
| 2011-03-31 | -$17.27M 10-Q · filed 2012-05-09 | -$29.63M derived: sum of 2 quarters · filed 2013-03-01 | -$31.09M derived: sum of 3 quarters · filed 2013-03-01 | |
| 2010-12-31 | -$12.36M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | -$13.82M derived: sum of 2 quarters · filed 2013-03-01 | $6.42M 10-K · filed 2013-03-01 | |
| 2010-09-30 | -$1.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07 | $18.78M 10-Q · filed 2011-11-07 | ||
| 2010-06-30 | $20.24M 10-Q · filed 2011-08-09 | |||
| 2009-12-31 | -$51.90M 10-K/A · filed 2012-03-30 |